Tumor-Derived Ligands Trigger Tumor Growth and Host Wasting via Differential MEK Activation

Developmental Cell - United States
doi 10.1016/j.devcel.2018.12.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer

Cancer Research
Cancer ResearchOncology
2018English

Tumor Targeting via Integrin Ligands

Frontiers in Oncology
Cancer ResearchOncology
2013English

Host miR155 Promotes Tumor Growth Through a Myeloid-Derived Suppressor Cell-Dependent Mechanism

Cancer Research
Cancer ResearchOncology
2014English

Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy

Cancer Research
Cancer ResearchOncology
2006English

Correction: Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1

Cancer Research
Cancer ResearchOncology
2009English

Exercise Against Tumor- And Chemotherapy-Induced Muscle Wasting

Biology, Engineering and Medicine
2018English

PPARγ Ligands Inhibit Primary Tumor Growth and Metastasis by Inhibiting Angiogenesis

Journal of Clinical Investigation
Medicine
2002English

Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)

American Journal of Pathology
Forensic MedicinePathology
2006English

Host-Tumor Interactions

Cancer Control
MedicineOncologyHematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy